Structural studies and molecular dynamics simulations suggest a processive mechanism of exolytic lytic transglycosylase from Campylobacter jejuni

PloS One
Jagamya VijayaraghavanFocco van den Akker

Abstract

The bacterial soluble lytic transglycosylase (LT) breaks down the peptidoglycan (PG) layer during processes such as cell division. We present here crystal structures of the soluble LT Cj0843 from Campylobacter jejuni with and without bulgecin A inhibitor in the active site. Cj0843 has a doughnut shape similar but not identical to that of E. coli SLT70. The C-terminal catalytic domain is preceded by an L-domain, a large helical U-domain, a flexible linker, and a small N-terminal NU-domain. The flexible linker allows the NU-domain to reach over and complete the circular shape, using residues conserved in the Epsilonproteobacteria LT family. The inner surface of the Cj0843 doughnut is mostly positively charged including a pocket that has 8 Arg/Lys residues. Molecular dynamics simulations with PG strands revealed a potential functional role for this pocket in anchoring the negatively charged terminal tetrapeptide of the PG during several steps in the reaction including homing and aligning the PG strand for exolytic cleavage, and subsequent ratcheting of the PG strand to enhance processivity in degrading PG strands.

References

Dec 1, 1975·Journal of Bacteriology·J V HöltjeU Schwarz
Jan 5, 1993·Journal of Molecular Biology·G D Van DuyneJ Clardy
May 5, 1994·The New England Journal of Medicine·J ParsonnetG D Friedman
Aug 1, 1993·FEMS Microbiology Letters·T RomeisJ V Höltje
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Apr 8, 1998·Microbiology and Molecular Biology Reviews : MMBR·J V Höltje
Jan 4, 2001·Journal of Molecular Evolution·N T Blackburn, A J Clarke
Aug 22, 2001·Protein Science : a Publication of the Protein Society·W A Breyer, B W Matthews
Aug 23, 2001·Proceedings of the National Academy of Sciences of the United States of America·N A BakerJ A McCammon
Sep 15, 2001·The New England Journal of Medicine·N UemuraR J Schlemper
Jan 23, 2003·Protein Engineering·Richard A George, Jaap Heringa
Jul 24, 2004·Acta Crystallographica. Section D, Biological Crystallography·Alexander W Schüttelkopf, Daan M F van Aalten
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·Dorota KorsakWaldemar Vollmer
Oct 14, 2005·Journal of Computational Chemistry·James C PhillipsKlaus Schulten
Nov 7, 2006·Journal of Bacteriology·Catherine ChaputIvo G Boneca
May 1, 2007·The International Journal of Biochemistry & Cell Biology·Edie ScheurwaterAnthony J Clarke
Sep 27, 2008·Bioinformatics·L HolmA Schenkel
May 13, 2009·Journal of Chemical Information and Modeling·Thomas A Halgren
May 26, 2009·Acta Crystallographica. Section D, Biological Crystallography·Thomas C TerwilligerLi Wei Hung
May 30, 2009·Proceedings of the National Academy of Sciences of the United States of America·Michele LunelliMichael Kolbe
Jan 9, 2010·Acta Crystallographica. Section D, Biological Crystallography·Alexei Vagin, Alexei Teplyakov
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Dec 15, 2010·Cell Stress & Chaperones·Rudi Kenneth Allan, Thomas Ratajczak
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Garib N MurshudovAlexei A Vagin
Dec 29, 2011·Nature Reviews. Microbiology·Athanasios TypasWaldemar Vollmer
Mar 22, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mathilde BonisIvo G Boneca
Apr 17, 2012·Acta Crystallographica. Section D, Biological Crystallography·Pavel V AfoninePaul D Adams
Feb 8, 2013·Protein Science : a Publication of the Protein Society·Jieming ChenLynne Regan
Feb 21, 2013·Journal of the American Chemical Society·Mijoon LeeShahriar Mobashery
Mar 6, 2013·Infection and Immunity·Abofu AlemkaChristine M Szymanski

❮ Previous
Next ❯

Citations

Nov 21, 2019·Protein Science : a Publication of the Protein Society·Jed F Fisher, Shahriar Mobashery

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
differential scanning fluorimetry
gel filtration
transglycosylase

Software Mentioned

GraphPad Prism
DALI
Refmac
Phenix
Molrep
PISA
SiteMap
Autosol
PRODRG
VMD

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Protein Structures (ASM)

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.